Sofinnova Management VIII, L.L.C.
For the details of Sofinnova Management VIII, L.L.C.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Sofinnova+Management+VIII%2C+L.L.C.
These are the top 5 holdings of Sofinnova Management VIII, L.L.C.
- Aclaris Therapeutics Inc ( ACRS ) - 1,539,480 shares, 24.21% of the total portfolio. Shares reduced by 32.76%
- ObsEva SA ( OBSV ) - 3,749,623 shares, 20.59% of the total portfolio. New Position
- Spark Therapeutics Inc ( ONCE ) - 699,430 shares, 19.68% of the total portfolio. Shares reduced by 22.71%
- Versartis Inc ( VSAR ) - 1,563,260 shares, 17.6% of the total portfolio. Shares reduced by 33.82%
- Natera Inc ( NTRA ) - 1,550,280 shares, 7.25% of the total portfolio.
New Purchase: ObsEva SA ( OBSV )
Sofinnova Management VIII, L.L.C. initiated holdings in ObsEva SA. The purchase prices were between $10.41 and $13.99, with an estimated average price of $12.28. The stock is now traded at around $8.13. The impact to the portfolio due to this purchase was 20.59%. The holdings were 3,749,623 shares as of 2017-03-31.
Added: Auris Medical Holding AG (EARS)
Sofinnova Management VIII, L.L.C. added to the holdings in Auris Medical Holding AG by 34.38%. The purchase prices were between $0.67 and $1.27, with an estimated average price of $1. The stock is now traded at around $0.77. The impact to the portfolio due to this purchase was 0.97%. The holdings were 7,818,175 shares as of 2017-03-31.
Reduced: Aclaris Therapeutics Inc ( ACRS )
Sofinnova Management VIII, L.L.C. reduced to the holdings in Aclaris Therapeutics Inc by 32.76%. The sale prices were between $25.1 and $32.65, with an estimated average price of $28.83. The stock is now traded at around $31.95. The impact to the portfolio due to this sale was -11.46%. Sofinnova Management VIII, L.L.C. still held 1,539,480 shares as of 2017-03-31.
Reduced: Versartis Inc ( VSAR )
Sofinnova Management VIII, L.L.C. reduced to the holdings in Versartis Inc by 33.82%. The sale prices were between $13 and $23.05, with an estimated average price of $17.58. The stock is now traded at around $20.25. The impact to the portfolio due to this sale was -6.7%. Sofinnova Management VIII, L.L.C. still held 1,563,260 shares as of 2017-03-31.
Reduced: Spark Therapeutics Inc ( ONCE )
Sofinnova Management VIII, L.L.C. reduced to the holdings in Spark Therapeutics Inc by 22.71%. The sale prices were between $52.41 and $65.02, with an estimated average price of $59.37. The stock is now traded at around $50.17. The impact to the portfolio due to this sale was -5.77%. Sofinnova Management VIII, L.L.C. still held 699,430 shares as of 2017-03-31.
- Warning! GuruFocus has detected 1 Warning Sign with EARS. Click here to check it out.
- EARS 15-Year Financial Data
- The intrinsic value of EARS
- Peter Lynch Chart of EARS
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
